ArticleEndocrine, metabolic & immune disorders drug targets2026
Exploring the Potential Molecular Targets of Cyanidin-3-O-glucoside for Type 2 Diabetes Mellitus Treatment.
Wenling Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.